Pradaxa Lawsuit News

10/19/2012 Pradaxa Lawsuit News : Pradaxa Lawsuit cases continue to be filed in State and Federal Courts around the nation. Many of the Pradaxa Lawsuit cases that have been filed have already been transferred to the Pradaxa Lawsuit Multidistrict litigation that has been formed in Federal Court in Illinois under the authority of the Federal Judicial Panel on Multidistrict Litigation. If you or a family member took Pradaxa and suffered a bleeding event that required medical attention you may be eligible to file a Pradaxa Lawsuit. Contact us today on our toll free number to arrange a free consultation with a Pradaxa Lawyer.

Pradaxa Lawsuit Defendant Working on Antidote

One of the central claims in the ongoing Pradaxa Lawsuit is the fact that the antidote well known to help stop bleeding events common to drugs like Pradaxa, did not work with Pradaxa. Pradaxa Lawsuit filings allege that the manufacturer of Pradaxa failed to warn users of Pradaxa that the antidote that had been used for years to help stop bleeding caused by similar drugs, did not work with bleeds caused by Pradaxa. It has been reported that the maker of Pradaxa is working on an antidote that will help stop Pradaxa Bleeding events however, the development of an antidote could take an undetermined length of time.

The fact that the maker of Pradaxa, who is the primary defendant in the Pradaxa Lawsuit is now working on an Antidote is of no benefit to those who have already suffered injury or death as a result of a bleed caused by or made worse by Pradaxa. Some Pradaxa Lawyers are of the opinion that the fact that the maker of Pradaxa is now working on an Antidote for Pradaxa bleeding events is evidence that the makers of Pradaxa should have created such an Antidote before releasing their product to the market. In addition, the Pradaxa Lawsuit defendant either did know or should have known that the Antidote used to help stop bleeds in drugs similar to Pradaxa, did not work to help stop Pradaxa Bleeding. The drug maker was obiligated to test their product to insure that it was safe before releasing it to the market. Testing to see if the common Antidote for drugs similar to Pradaxa, also worked with Pradaxa was something that the manufacturer logically should have done.

Did the Pradaxa Lawsuit Defendant Text the Antidote?

It is unknown to us at this time if the Pradaxa Lawsuit defendant tested the common antidote for Pradaxa Bleeding events prior to releasing the product to the market. If the maker of Pradaxa did test the common antidote then they had prior knowledge that the Antidote did not work with Pradaxa. If the maker of Pradaxa was aware that the Antidote did not work with Pradaxa then they were obligated to inform the public as well as the Food and Drug Administration of this fact.

What are the marketing issues in the Pradaxa Lawsuit?

Pradaxa was marketed by its manufacturer as being superior to other drugs used to treat the same condition that Pradaxa was created to treat. The fact that the common antidote did not work with Pradaxa Bleeds has led to Pradaxa Lawsuit claims that the Pradaxa Lawsuit Defendant engaged in false and misleading advertising when they claimed that Pradaxa was superior to other drugs approved by the United States food and drug administration to treat the same condition that Pradaxa was created to treat.

Filing a Pradaxa Lawsuit

If you believe you have cause to file a Pradaxa Lawsuit it is in your best interest to contact a Pradaxa Lawyer as soon as possible. You can arrange a free consultation with a Pradaxa Lawyer by contacting our toll free number at 1-800-611-7080.